Midwest for Kaliningrad
Our missionary trip to the City of Kaliningrad, Russia
June 2013
THANK YOU
Dear Friends, thank you for your generous contributions to the MFK programs: Cancer Treatment facilities, Cancer Support Group and Hospices. YOU made and continue to make a difference in the lives of Russian elderly, oncology patients and hospice
residents! Thank you again for your compassion.
Yuliya Antropova-Elder on behalf of Midwest for Kaliningrad
TRAVELLING to RUSSIA
PLEASE NOTE that Midwest for Kaliningrad DOES NOT pay travel
expenses including but not limited to airfare, transportation, room/board etc.
The MFK volunteers are personally responsible for their travel expenses. The MFK funds are specifically used
only for the MFK programs.
TIVAS (totally implantable vascular access devices)
a/k/a access ports (e.g. Celsite)
• MFK raised almost $5,000 last year (2012) and Yuliya went to Russia in June 2012 and bought 12
sets of Celsite (access ports) used for administering chemotherapy to oncology patients. The Celsite access ports produced by BBraun (a US based
medical device manufacturer) are now available for purchase in Russia.
•http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/products.html?prid=PRID00000992
BBraun in Russia
• In the spring of 2012 we learned that BBraun has two subsidiaries in Russian Federation;
• We identified and located BBraun distributors in Kaliningrad and inquired whether the ports can be ordered from Bbraun’s subsidiary in St. Petersburg
• The response was “Yes!”
• MFK entered into an agreement with the Kaliningrad medical devices’ distributors and our Celsite ports were successfully shipped to Kaliningrad where Yuliya finalized the purchase.
What is the function of access ports (Celsite)?
• Treatment of patients (e.g. in oncology, haematology, internal medicine) often requires long-term vascular or extra-vascular access connected to an access port for drug delivery, drainage, blood sampling, transfusions,
TPN... An implantable device made of a reservoir connected to a catheter that enables continuous access can increase the patients’ quality of life. Using Celsite® Access Ports for long-term treatment delivery provides
numerous advantages for patients, nursing staff, physicians and hospital administrators
We purchased Celsite ports from BBraun subsidiary in St. Petersburg
CELSITE Indication
Venous access ports are intended to be used for repeated intra-venous administration of, for
example, chemotherapy, antibiotic and anti-viral drugs, parenteral nutrition, blood sampling or
transfusion. Certain Celsite® Access Ports may be used for Contrast Enhanced Computerised
Tomography (CECT) using high pressure injection.
Celsite access ports
Celsite® Power Injectable Access Ports
Sharing the results of 2012 MFK Fundraising efforts with the Kaliningrad Regional Hospital administration
MFK donation of Celsite ports was properly documented
Yuliya with Chief Doctor of Kaliningrad Reginal Hospital Dr. Konstantin Poliakov and the Head of
Medical Oncology Division, Dr. Michail Popov
The representatives of the Kaliningrad Regional Hospital administration asked MFK to consider helping
them with Celsite ports in the future
Thank you Midwest for Kaliningrad!
THANK YOU ALL
FOR YOUR KIND HEARTS, COMPASSIONATE SOULS AND YOUR
WILLINGNESS TO SHARE.
THANK YOU FOR YOUR CONTIONUOUS SUPPORT OF THE MIDWEST FOR
KALININGRAD PROGRAMS.
Yuliya & Michael Elder on behalf of Midwest for Kaliningrad